Literature DB >> 23182557

Evaluation and treatment of anovulatory and unexplained infertility.

Anthony M Propst1, G Wright Bates.   

Abstract

Anovulatory disorders are a primary cause of female infertility. Polycystic ovarian syndrome is the major cause of anovulation and is generally associated with obesity. Lifestyle changes to encourage weight loss are the initial therapy for overweight and obese patients, followed by clomiphene citrate for ovulation induction. For those patients who fail to ovulate on clomiphene citrate, alternatives, such as letrozole; gonadotropins; and complimentary agents to enhance clomiphene citrate, such as metformin and glucocorticoids, are reviewed. Women with unexplained infertility (no identifiable cause of infertility on a routine evaluation) may benefit from ovulation induction with clomiphene citrate, letrozole, or gonadotropins.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23182557     DOI: 10.1016/j.ogc.2012.09.008

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  3 in total

Review 1.  Chinese medicine as complementary therapy for female infertility.

Authors:  Ju-Feng Xia; Yoshinori Inagaki; Jian-Feng Zhang; Ling Wang; Pei-Pei Song
Journal:  Chin J Integr Med       Date:  2016-08-02       Impact factor: 1.978

2.  The Roles of Anandamide, Fatty Acid Amide Hydrolase, and Leukemia Inhibitory Factor on the Endometrium during the Implantation Window.

Authors:  Na Cui; Changyan Wang; Zhiming Zhao; Jie Zhang; Yueming Xu; Yang Yang; Guimin Hao
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-16       Impact factor: 5.555

3.  A comparison of oral versus injectable ovarian stimulation in IUI in women ≥38 years of age with decreased ovarian reserve.

Authors:  Russell Frank; Naama Steiner; Maryam Al Shatti; Jacob Ruiter-Ligeti; Michael H Dahan
Journal:  Arch Gynecol Obstet       Date:  2021-01-03       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.